ArticleBlood science (Baltimore, Md.)2025
A drop-based workflow for fast and robust joint profiling of transcriptome and chromatin accessibility in the same cell.
Article in Blood science (Baltimore, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell multiomics technologies have significantly advanced our understanding of cellular heterogeneity and biological complexity. The joint profiling of single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) within the same cell offers a powerful approach for enabling direct linkage between gene expression and chromatin accessibility at single-cell resolution. This integration significantly enhances sensitivity and specificity in identifying rare cell populations and elucidating epigenetic regulatory mechanisms. In this study, we present a robust, high-throughput droplet-based microfluidic protocol that enables simultaneous profiling of RNA and chromatin accessibility from individual cells. The streamlined workflow incorporates key steps, including cell pretreatment, nuclei isolation, gel bead-in-emulsion (GEM) generation, and the construction of scRNA-seq and scATAC-seq libraries. The protocol supports parallel processing of tens of thousands of cells in a single experiment, offering exceptional scalability and reproducibility. The multimodal nature of this approach allows for integrative analysis of multiple features from the same cell, making it an invaluable tool for dissecting complex biological systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.